| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/18/2006 | WO2006032697A3 MODIFIED VPl-CAPSID PROTEIN OF PARVOVIRUS B19 |
| 05/18/2006 | WO2006032436A3 Use of microproteins as tryptase inhibitors |
| 05/18/2006 | WO2006026663A9 Methods for treating congestive heart failure |
| 05/18/2006 | WO2006023356A3 Selective vpac2 receptor peptide agonists |
| 05/18/2006 | WO2006015297A3 Methods of treating type i diabetes by blocking vegf-mediated activity |
| 05/18/2006 | WO2006015005A3 Use of thyrotropin for regeneration of bone |
| 05/18/2006 | WO2006000867B1 Compositions for topical treatment |
| 05/18/2006 | WO2005123760A3 Treating cancer |
| 05/18/2006 | WO2005120540A3 Interferon alpha or beta for treatment of cardiomyopathy and endothelial dysfunction |
| 05/18/2006 | WO2005118840A3 Diagnostics and therapeutics for diseases associated with kallikrein 10 (klk10) |
| 05/18/2006 | WO2005117941A3 Methods and compositions for the treatment of polycystic diseases |
| 05/18/2006 | WO2005117895A8 Compositions comprising meloxicam |
| 05/18/2006 | WO2005115440A3 Compositions and method for modulating insulin-activated nitric oxide synthase |
| 05/18/2006 | WO2005115333A3 A biomolecule-containing formulation of increased stability |
| 05/18/2006 | WO2005115149A3 Insectidal activity of a cyclic peptide |
| 05/18/2006 | WO2005112864A3 Method for fostering bone formation and preservation |
| 05/18/2006 | WO2005108432A3 Cd80 (b7-1) binding peptides and uses thereof |
| 05/18/2006 | WO2005100392A3 Treatment of neuropathic pain with zinc finger proteins |
| 05/18/2006 | WO2005094497A3 Systemic delivery of therapeutics to central nervous system |
| 05/18/2006 | WO2005087806A3 Cd38 splice variant and uses thereof |
| 05/18/2006 | WO2005077044A3 Rational design and engineering of proteins and peptides for immunomodulation |
| 05/18/2006 | WO2005069758A3 Frequency assisted transdermal agent delivery method and system |
| 05/18/2006 | WO2005063202A3 Method for preparing solid dosage form of desmopressin |
| 05/18/2006 | WO2005058283A3 Stabilised compositions of factor vii polypeptides |
| 05/18/2006 | WO2005056055A3 METHODS OF PROTECTING AGAINST RADIATION USING INDUCERS OF NF-κB |
| 05/18/2006 | WO2005041866A3 Pharmaceutical formulations, methods and dosing regimens for the treatment and prevention of acute coronary syndromes |
| 05/18/2006 | WO2005041852A3 Keratin gel and the types 2, 4 and 6 of collagens of frog protein |
| 05/18/2006 | WO2005035550A3 Dual phase-pna conjugates for the delivery of pna through the blood brain barrier |
| 05/18/2006 | WO2005011620A3 Methods and apparatus for creating particle derivatives of hdl with reduced lipid content |
| 05/18/2006 | WO2004058939A3 TRANSLATIONAL CONTROL BY SMALL, NON-TRANSLATABLE RNAs |
| 05/18/2006 | WO2004006837A3 Mesothelin vaccines and model systems |
| 05/18/2006 | WO2002096356A3 HIGH AFFINITY LIGAND FOR p75 NEUROTROPHIN RECEPTOR |
| 05/18/2006 | US20060107353 Plant bioreactors |
| 05/18/2006 | US20060106204 Bifunctional energy-reversible acyl-compositions |
| 05/18/2006 | US20060106202 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 05/18/2006 | US20060106198 Peptides corresponding to active site of N-terminal extension of subunits composing specific adhesive organelles of virulence of pathogenic bacteria; inhibit surface expression of adhesive organelles and thus prevent development of infections; decrease therapeutic dose; reduce side effects |
| 05/18/2006 | US20060106197 comprises protein transduction domains; nuclear localization sequences; fusion proteins; for reversible immortalization of cells |
| 05/18/2006 | US20060106196 treatment or prophylaxis of cancer using proteins or peptides that elicit T cell mediated immunity; vaccination |
| 05/18/2006 | US20060106110 Modified amino acid is N-(-5-chlorosalicyloyl)-8-aminocaprylic acid; active agents are heparin, insulin, parathyroid hormone, calcitonin; cardiovascular disorders |
| 05/18/2006 | US20060105994 Treatment of prostate cancer |
| 05/18/2006 | US20060105993 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 05/18/2006 | US20060105982 Non-invasive gene targeting to ocular cells |
| 05/18/2006 | US20060105981 Therapeutic agents for treatment of solid tumors comprising an expression-inhibiting substance against Wilms' tumor gene (WT1) |
| 05/18/2006 | US20060105974 Conjugates of photosensitizers and oligonucleotides for selective photochemiotherapy |
| 05/18/2006 | US20060105973 nucleosides, phosphorothioate linkages; colloids; osteoporosis; depression; metabolic disorders such as obesity, diabetes, atherosclerosis and hyperlipidemia |
| 05/18/2006 | US20060105960 New selenohydroxy acids and their derivatives, applications in nutrition, cosmetics and pharmaceutics |
| 05/18/2006 | US20060105959 Organic compounds with biological action as thrombin inhibitors and use thereof |
| 05/18/2006 | US20060105958 Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis |
| 05/18/2006 | US20060105957 Loop peptide and TGFalpha for stimulating stem cell proliferation and migration |
| 05/18/2006 | US20060105956 Phenotypic reversion of pancreatic carcinoma cells |
| 05/18/2006 | US20060105955 Insulin entrapped within crystallized lecithin, including ascorbyl palmitate and lipoic acid, transdermal delivery |
| 05/18/2006 | US20060105954 Glucagon-like peptide-2 and its therapeutic use |
| 05/18/2006 | US20060105953 Polynucleotide encoding polypeptide which is protected from proteosomal degradation by cleavage of linking group; |
| 05/18/2006 | US20060105952 Annexin V is used to prevent thrombosis without increasing hemorrhage; annexin binds to phosphatidylserine on outer surface of cell membranes, thereby preventing binding of prothrombinase complex necessary for thrombus formation |
| 05/18/2006 | US20060105951 Melanocortin receptor binding mimetibodies, compositions, methods and uses |
| 05/18/2006 | US20060105950 Morphogen compositions and use thereof to treat wounds |
| 05/18/2006 | US20060105949 Pharmaceutical preparations and methods for inhibiting tumors |
| 05/18/2006 | US20060105948 GLP-2 derivatives |
| 05/18/2006 | US20060105947 Novel chimeric analgesic peptides |
| 05/18/2006 | US20060105946 Method for treating the central nervous system by administration of igf structural analogs |
| 05/18/2006 | US20060105945 For treatment of mucin deficiency (dry mouth syndrome, achlorhydria, mucous cysts, oral submucous fibrosis, oral nevi, oral mucosa cancer, maloplakia of the genito-urinary tract, vulvovaginitis, helicobacter plylori infection, ulcers, peptic ulcers, conditions affecting the uterus and appendicitis) |
| 05/18/2006 | US20060105944 Topically administering cyclosporin A in a rectal suppository to treat inflammatory bowel disease and ulcerative colitis |
| 05/18/2006 | US20060105943 Administering cyclic peptides; arthritis, inflammations, osteoporosis, retinopathies, contraception |
| 05/18/2006 | US20060105942 Inhibition of cell division based use of analogs of neuropeptide y |
| 05/18/2006 | US20060105941 Mixed antibiotic codrugs |
| 05/18/2006 | US20060105940 Compound useful in the treatment or prevention of cognitive disorders associated with diabetes and associated methods |
| 05/18/2006 | US20060105939 Treatment of autism and similar disorders |
| 05/18/2006 | US20060105938 Method of treating or preventing obeisity and lipid metabolism disorders and compositions for use therein |
| 05/18/2006 | US20060105446 Biodegradable, resistant to nitrate salt, hardly forms spores, does not contain any plasmids; food and beverage additive; cosmetics |
| 05/18/2006 | US20060105445 Medium and method for enriching, purifying or depleting atp binding proteins from a pool of proteins |
| 05/18/2006 | US20060105430 cleaving a heparin-like glycosaminoglycan using modified heparinases having altered binding specificity and activity; angiogenesis inhibition |
| 05/18/2006 | US20060105429 Nucleic acid encoding protein which comprises hormone and has higher plasma stability; maintains biological activity for prolonged period in body |
| 05/18/2006 | US20060105424 Nucleic acids which code for protein from Acremonium chrysogenum; host cells |
| 05/18/2006 | US20060105386 17867, a novel human aminopeptidase |
| 05/18/2006 | US20060105378 Tenascin-C nucleic acid ligands |
| 05/18/2006 | US20060105374 RhoB variants and methods of use |
| 05/18/2006 | US20060105347 Fetoproteins; pharmacokinetics; biocompatability; rheumatoid arthritis; multiple sclerosis; cancer |
| 05/18/2006 | US20060105333 Method for diagnosis of intestinal-type gastric tumors |
| 05/18/2006 | US20060105330 Diagnostics and remedies for malignant brain tumor |
| 05/18/2006 | US20060105327 Inhibition of the SRC kinase family pathway as a method of treating HBV infection and hepatocellular carcinoma |
| 05/18/2006 | US20060105071 Blood-viscosity reducing agent |
| 05/18/2006 | US20060105070 Extract is soluble in water and insoluble in an aqueous solution containing 65-90% ethanol; enhances the proliferation of bone marrow cells and spleen cells; administering to the subject an effective amount of a DsCEII extract from a tuber of a Dioscorea plant |
| 05/18/2006 | US20060105056 Oxygenated albumin for use as blood and blood extender |
| 05/18/2006 | US20060105048 Remedy |
| 05/18/2006 | US20060105042 axon regeneration kits comprising containers containing fibrinogen, thrombin, calcium chloride, poly/ADP-ribose/polymerase and N-(4-pyridyl)-4-(1-aminoethyl)-cyclohexanecarboamide and drug delivery devices; kinase inhibitors |
| 05/18/2006 | US20060105013 Osteopontin-coated surfaces and methods of use |
| 05/18/2006 | US20060105001 drugs specifically bound to synthetic receptors in such a manner that active drug becomes available only in the presence of a targeted pathophysiologic receptor; increasing efficacy and safety, while reducing side effects |
| 05/18/2006 | US20060104995 Combination of local botulinum toxin and oral triptan drug administration; preventing overuse; reducing pain sensory output |
| 05/18/2006 | US20060104992 Irreversibly-inactivated pepsinogen fragment and pharmaceutical compositions comprising this fragment for detecting, preventing, and treating HIV |
| 05/18/2006 | US20060104990 Mixture comprising group B streptococcal peptide for use in generating vaccine and immunoglobulins for diagnosis, prevention and treatment of urinary tract infections |
| 05/18/2006 | US20060104981 Prophylactic/therapeutic agent for cancer |
| 05/18/2006 | US20060104980 Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes |
| 05/18/2006 | US20060104977 Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells |
| 05/18/2006 | US20060104973 Inhibitors of Nogo Receptor (NgR)-p75 binding are used to reduce NgR-p75 binding mediated axon growth inhibition; myelins; for drug screening; cell-free; reducing myelin-mediated inhibition of axon regeneration |
| 05/18/2006 | US20060104972 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| 05/18/2006 | US20060104970 Biological glue based on thrombin-conjugated nanoparticles |
| 05/18/2006 | US20060104969 Compositions and methods for enhancing structural and functional nervous system reorganization and recovery |
| 05/18/2006 | US20060104968 soluble neutral active Hyaluronidase Glycoproteins (sHASEGPs); use treating glycosaminoglycan associated pathologies such as tumors or eye disorders; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes |
| 05/18/2006 | US20060104967 Method of converting the state of proteins |
| 05/18/2006 | US20060104966 Transglutaminase linkage of agents to tissue |